Infection of pigs with influenza A viruses is of substantial importance to the swine industry and to the epidemiology of human influenza (5, 19) . At present, three main subtypes of influenza viruses are circulating in the swine population throughout the world: subtypes H1N1, H3N2, and H1N2 (18) . In North America, influenza virus outbreaks among pigs have historically been due almost exclusively to infection with H1N1 viruses (3, 8, 20) . Since 1997-1998, however, H3N2 viruses have emerged and spread widely within the swine population (13, 18, 37, 40) . Triple-reassortant H3N2 viruses containing hemagglutinin (HA), neuraminidase (NA), and PB1 polymerase genes of human influenza virus origin, the matrix (M), nucleoprotein (NP), and nonstructural (NS) genes of classical swine influenza virus origin, and the PA and PB2 polymerase genes of avian influenza virus origin have been isolated widely throughout the United States. These viruses have been associated with outbreaks of respiratory disease in pigs of all ages and abortions in pregnant sows (13, 37, 40) . In addition, reassortment between these viruses and classical H1N1 viruses has led to the subsequent development of H1N2 viruses, which have also spread throughout the swine population of the United States (11, 12) . In contrast, an H3N2 virus in which all eight RNA segments were of human influenza virus origin was isolated from a single baby pig in 1997 on a farm in Ontario, Canada. This virus did not spread within the farm of origin and has not been recovered from pigs subsequent to its initial isolation (13) .
Influenza A viruses have been isolated from various species, including humans, pigs, horses, birds, sea mammals, and mink (39) . However, wild waterfowl serve as the reservoir from which all influenza viruses are thought to have emerged (39) . Despite their common origin, influenza A viruses are generally restricted in host range. In particular, avian influenza viruses replicate poorly in humans and nonhuman primates and human influenza viruses do not replicate well in birds (1, 7, 8, 14, 17, 19, 38, 39) . In contrast, swine influenza viruses have been shown repeatedly to infect humans as zoonotic infections, and conversely, human influenza viruses have also been isolated from pigs (19) . The host range restriction of influenza viruses is a polygenic trait (16, 27, 32, 33) , but the HA gene is considered to be a particularly important determinant since HA is responsible for attachment of the virus to sialic acid receptors on the host cell surface (9, 34, 39) . While human influenza viruses preferentially bind to sialic acid bound to galactose by ␣2,6 linkages, avian viruses preferentially recognize sialic acid bound by ␣2,3 linkages (9, 15, 25, 36) . This is consistent with the fact that human tracheal epithelial cells predominantly express ␣2,6-linked receptors, whereas avian intestinal cells predominantly express ␣2,3-linked receptors (4, 10). However, avian and human influenza viruses can both infect pigs because porcine respiratory epithelial cells express both N-acetylneuraminic acid-␣2,3-galactose and N-acetylneuraminic acid-␣2,6-galactose (10) . Pigs can therefore function as intermediate "mixing vessel" hosts in establishing new influenza virus lineages by supporting coinfection, replication, and reassortment among human, avian, and swine influenza viruses (19, 26, 27, 39) .
Even though influenza viruses can cross species barriers and infect pigs, it is not known what properties are necessary to allow a virus to form a stable lineage and to spread efficiently within the pig population. In particular, a wholly human H3N2 virus, A/Swine/Ontario/00130/97 (H3N2) (Sw/ONT), initially crossed the species barrier to infect a pig in Canada in 1997, but it did not infect other pigs in the herd (13) . Its disappearance may have been due to characteristics of the virus (i.e., its replication efficiency in pigs) or epidemiological factors (i.e., the availability of susceptible animals). In contrast, triple-reassortant H3N2 viruses containing genes from human, classical swine, and avian influenza viruses have spread throughout the swine population of the United States since 1998 (13, 37, 40) . The critical factors that affect replication ability in pigs may include the overall constellation of genes present in the triplereassortant viruses. However, we have also identified specific differences in the sequences of the HA genes of triple-reassortant viruses that may represent swine adaptation mutations (13) . As an initial step in understanding the pathogenesis of these viruses in pigs, the present study was designed to define the specific characteristics of these viruses, including their infectivities, replication kinetics, and ability to induce pathological lesions under experimental infection conditions.
MATERIALS AND METHODS
Animals and influenza viruses. Thirty-six domestic pigs were purchased from a commercial herd and shown to be serologically negative for prior exposure to porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, and H1 and H3 influenza viruses. The pigs were 6 weeks old at the start of the experiment and were maintained in accordance with the guidelines of the U.S. Department of Agriculture and the University of Wisconsin Research Animal Resources Center. Field isolates of A/Swine/Minnesota/593/99 (Sw/MN) (H3N2; generously provided by G. Anderson, ImmTech Biologics, LLC, Bucyrus, Kans.) and Sw/ONT (H3N2; generously provided by S. Carman, University of Guelph, Guelph, Ontario, Canada) were cultivated in Madin-Darby canine kidney (MDCK) cells. The viruses were grown in Eagle minimal essential medium (GIBCO/BRL) supplemented with 0.5% bovine serum albumin (GIBCO/ BRL), penicillin-streptomycin (GIBCO/BRL), amphotericin B (Fungizone; GIBCO/BRL) and tolylsulfonyl phenylalanyl chloromethyl ketone-treated trypsin (1 g/ml; Worthington Biochemical Corporation, Lakewood, N.J.). Sw/MN virus has previously been shown to contain the HA, NA, and PB1 genes of the human influenza virus lineage, the NP, M, and NS genes of the classical swine influenza virus lineage, and the PA and PB2 polymerase genes of the avian influenza virus lineage, whereas all eight RNA segments of Sw/ONT are of human influenza virus origin (13) .
Experimental design. The pigs were randomly assigned to nine cohorts of four pigs each and acclimated to biosafety level 2 housing for 1 week. On day 0 of the experiment, prior to inoculation, a short physical examination was performed to assess the general appearance of the animals (attitude, sneezing, and coughing were quantified on a scale of 0 to 3, with 0 indicating a clinically normal animal and 3 indicating a severely abnormal condition), their food intakes (with 0 indicating that the animal is eating and 1 indicating that the animal is off feed), respiratory rates (number of breaths per minute), and rectal temperatures. Thereafter, the pigs were weighed and preinoculation nasal swab (Dacron polyester; Hardwood Products Company, Guilford, Maine) samples for virus isolation and blood samples for serology and complete blood counts (CBCs) were collected. The pigs were then sedated by intramuscular injection of 0.5 mg of xylazine (Phoenix Pharmaceutical) per kg of body weight and 2 mg of tiletamine plus zolazepam (Telazol; Fort Dodge) per kg and inoculated intranasally with either Sw/MN or Sw/ONT at 2 ϫ 10 3 , 2 ϫ 10 4 , 2 ϫ 10 5 , or 2 ϫ 10 6 50% tissue culture infective doses (TCID 50 s). Four pigs were inoculated with each dose of virus, and four pigs in a ninth cohort were mock inoculated to serve as uninfected controls. At daily intervals after inoculation, the animals were assessed clinically and nasal swab samples were obtained from each animal. The swabs were placed in 1 ml of viral transport medium containing phosphate-buffered saline (PBS), 0.5% bovine serum albumin, and the antimicrobials penicillin G, streptomycin, nystatin, and gentamicin and stored at Ϫ80°C until further analysis. Blood samples for serology were collected from all animals on day 7, and repeat CBCs were performed on days 3 and 7 for animals infected with 2 ϫ 10 6 TCID 50 s of either virus and the uninfected control animals.
Evaluation of pathological lesions. On day 7 the animals were euthanized by exsanguination following anesthesia by intramuscular injection of 4 mg of xylazine per kg and 4 mg of tiletamine-zolazepam per kg. The lungs were removed for postmortem analysis. Macroscopic pulmonary lesions were graded on the basis of the percentage of the surface area of each lung lobe exhibiting gross pathological evidence of tissue consolidation. The values for the individual lobes were averaged to obtain the overall percentage of lung tissue consolidation for each pig. Sections of lung tissue were obtained from a standardized location (left cranial lung lobe) and fixed in 4% buffered formalin, embedded in paraffin, cut in 6-m-thick sections, and stained with hematoxylin-eosin. Each histological section was evaluated by a board-certified pathologist, without knowledge of the animal's infection status, for a variety of parameters of pulmonary pathology (atelectasis, epithelial necrosis, hemorrhage, airway plugging, epithelial hyperplasia, interstitial changes, leukocyte infiltration). Each individual parameter was given a score ranging from 0 to 3, with 0 indicating no abnormalities and 3 indicating severe abnormalities. These scores were added to obtain an overall score for each section.
Evaluation of virus shedding. To determine the extent of virus shedding in nasal secretions, 10-fold serial dilutions of the viral transport medium containing the nasal swabs were inoculated (in duplicate) onto MDCK cells grown in 48-well tissue culture plates, and the plates were incubated for 72 h at 37°C with 5% CO 2 . The presence of virus replication in each well was confirmed by immunocytochemical staining with a mouse anti-NP monoclonal antibody (monoclonal antibody 68D2; kindly provided by M. McGregor and Y. Kawaoka, University of Wisconsin-Madison). All incubation steps were carried out at room temperature. Prior to staining, the cells were fixed for 30 min in 10% phosphate-buffered formalin and washed with PBS. Subsequently, the cells were incubated for 30 min with 0.3% H 2 O 2 -methanol and washed in PBS. Following fixation, the cells were incubated with serum blocking solution (nonimmune horse serum) for 30 min and subsequently incubated with a 1:1,000 dilution of anti-NP monoclonal antibody-containing ascitic fluid for 1 h. After the cells were washed in PBS, they were incubated with biotinylated secondary antibody for 30 min and washed in PBS; this was followed by 45 min of incubation with the avidin-biotin conjugate (Vectastain Elite kit; Vector Laboratories Inc., Burlingame, Calif.). Finally, the color was developed with the chromogen aminoethyl carbazole (Zymed Laboratories Inc., San Francisco, Calif.). Each staining procedure contained an isotype-matched negative control antibody and mock-infected negative control cells. The titer of virus in each specimen, expressed as the number of TCID 50 s per milliliter, was calculated by the method of Reed and Muench (24) .
HA inhibition assay. The levels of hemagglutination (HA)-inhibiting (HI) antibodies in serum samples were determined as described previously (22) . Briefly, sera were incubated overnight at 37°C with 4 volumes of receptordestroying enzyme (Denka Seiken Co., Tokyo, Japan) prepared from Vibrio cholerae. After inactivation of the receptor-destroying enzyme by incubation of the samples at 56°C for 60 min, twofold serial dilutions of sera were mixed with 4 HA units of Sw/MN or Sw/ONT. The assays were developed by adding 0.5% (vol/vol) chicken red blood cells, and the HI antibody titers were defined as the reciprocal of the highest dilution causing complete inhibition of agglutination.
Statistical analysis. All values are expressed as the means Ϯ standard errors of the means (SEMs). Data between treatment groups were analyzed by the t test or one-way analysis of variance. When F was significant (P Յ 0.05), further differences between means were determined by Tukey's omega procedure. Means were considered significantly different at P values Յ0.05.
RESULTS AND DISCUSSION
Clinical responses to infection and CBC data. Only mild changes in the clinical appearances of the animals were observed in this study. However, this is not unusual in our experience (unpublished results) when pigs are infected intranasally with influenza virus in a clean isolation environment. The general condition of the animals and food intake were unchanged in all treatment groups during the present experiment. In addition, no significant changes in the amount of sneezing and coughing between animals in the virus challenge groups and the control animals were observed (data not shown). Animals infected with Sw/MN showed a mild increase in respiratory rates compared to those of animals infected with Sw/ONT on days 6 and 7 of infection, but these changes were significant TCID 50 s. The changes in CBCs observed between pigs infected with the different viruses were minimal. There were no significant differences in the number of total white blood cells, neutrophils, lymphocytes, or monocytes/macrophages between and within the virus challenge groups and the controls on days 0, 3, and 7. Finally, during the course of the experiment, animals infected with Sw/MN had overall decreased rates of weight gains compared to those for the control animals and the Sw/ONT-infected pigs. These changes were significantly different for pigs challenged with 2 ϫ 10 6 TCID 50 s of Sw/MN when the results were compared to those for the pigs challenged with the corresponding dose of Sw/ONT.
Macroscopic and histological pulmonary lesions. The lungs of all control animals had no grossly visible signs of pulmonary disease at the time of necropsy. With the exception of one animal that received the highest challenge dose, pigs inoculated with Sw/ONT developed only very mild macroscopic pulmonary lesions. However, all pigs infected with Sw/MN at any dose exhibited obvious signs of pulmonary pathology. The percentages of overall lung tissue consolidation among the Sw/ MN-inoculated pigs were higher compared to those among the Sw/ONT-inoculated animals, and these differences were statistically significant at 2 ϫ 10 4 and 2 ϫ 10 5 TCID 50 s ( Table 1 ). The degrees of macroscopic lung pathology were mirrored by the changes found histologically. Characteristic swine influenza lesions consisting of epithelial cell damage, airway plugging, and peribronchial and perivascular infiltration by inflammatory cells (35) were present in all animals infected with the Sw/MN triple reassortant. Pigs infected with the wholly human Sw/ONT virus generally showed only mild signs of pneumonia, and the overall histological scores were significantly lower at all challenge doses compared to those for the pigs challenged with the triple-reassortant virus (Table 1) .
Virus shedding. The kinetics and absolute levels of virus shedding were remarkably different for the two viruses (Fig. 1) . All pigs inoculated with the Sw/MN triple reassortant shed detectable levels of virus for at least 3 days over the course of the experiment. The mean duration of shedding was 4.3 days. Animals infected with 2 ϫ 10 5 and 2 ϫ 10 6 TCID 50 s of Sw/MN generally began shedding virus on day 1, and the highest titers (2 ϫ 10 7.5 TCID 50 s/ml) were reached by day 3, while pigs infected with the lower doses generally began shedding on day 2 or 3 and the highest titers were reached on day 4. In contrast, among animals inoculated with Sw/ONT, three pigs (one each receiving a challenge dose of 2 ϫ 10 3 TCID 50 s, 2 ϫ 10 5 TCID 50 s, and 2 ϫ 10 6 TCID 50 s) never shed influenza virus at any detectable levels. In addition, the overall mean shedding time was only 2.7 days for the Sw/ONT-inoculated pigs. While three pigs infected with 2 ϫ 10 6 and 2 ϫ 10 5 TCID 50 s shed virus beginning on day 1, animals inoculated with the lower doses did not begin shedding until much later, day 4 to day 6.
The nasal virus titers were also higher in triple-reassortant Sw/MN-infected animals than in the pigs infected with wholly human Sw/ONT influenza virus. At the lowest challenge dose, nasal virus titers in the Sw/MN-infected pigs were significantly higher on days 2, 3, and 4. In pigs inoculated with 2 ϫ 10 4 or 2 ϫ 10 5 TCID 50 s of virus, nasal virus titers in the Sw/MNinfected pigs were significantly higher on days 2 to 5 and days 1 to 4, respectively. Finally, the pigs infected with Sw/MN at 2 ϫ 10 6 TCID 50 s shed significantly more virus on day 3. While the triple-reassortant H3N2 influenza virus was able to infect all pigs at each challenge dose, the wholly human virus did not. These findings are consistent with the observation made at the time of the initial isolation of Sw/ONT that this virus did not spread to other pigs in the population. This observation and our experimental results suggest that the wholly human Sw/ONT influenza virus is not as replication competent in pigs as Sw/MN is. Specifically, Sw/ONT may not enter host cells as readily as Sw/MN, and/or Sw/ONT may not be able to replicate efficiently enough and may not be shed in sufficient quantities to promote pig-to-pig transmission. Preliminary results of an in vitro study comparing the infectivities and replication kinetics of these two viruses (data not shown) suggest that there are substantial differences between the Sw/ Ont and Sw/MN viruses during the initial steps of host cell infection and the initiation of replication. Such differences in virus entry and/or replication initiation at the cellular level could explain the differences in infectivities and virus shedding kinetics observed in our pig experiment. While the pigs in the cohorts infected with 2 ϫ 10 3 TCID 50 s of either virus showed substantial differences in nasal virus titers and shedding kinetics, these differences became less obvious at higher initial infectious doses. These findings suggest that with an inoculum of 2 ϫ 10 3 TCID 50 s of Sw/MN, most of the available respiratory cells became infected and an increase in the infectious dose did not substantially change nasal virus titers or shedding kinetics. In comparison, the number of respiratory cells that were in- fected with 2 ϫ 10 3 TCID 50 s of Sw/ONT was likely much lower, and by increasing the infectious dose, the number of infected cells also increased proportionally until it reached levels comparable to those of Sw/MN. HI antibody responses. All pigs were serologically negative for swine influenza virus on day 0. With the exception of one pig in the group receiving the lowest challenge dose, virusspecific antibody titers, as measured by the HI assay, were present in the sera of all Sw/MN-infected pigs by day 7 (Table  1) . In contrast, with the exception of three pigs (one in the group receiving 2 ϫ 10 6 TCID 50 s, two in the group receiving 2 ϫ 10 5 TCID 50 s), none of the pigs inoculated with Sw/ONT developed detectable antibody titers by day 7, and the titers in these three pigs were low (1:60 for the pig in the group receiving 2 ϫ (39) , so the successful survival of a particular virus strain within a population is likely dependent on the efficient infection of new hosts (6) . This implies that in order for a virus to establish a stable lineage within a host species, the virus must infect and replicate efficiently in these hosts.
The results of our study indicate that triple-reassortant H3N2 virus Sw/MN infected and replicated efficiently in pigs, while the levels of replication and shedding of wholly human H3N2 virus Sw/ONT were much lower. The first step of influenza virus entry is dependent on the interaction of the viral HA with cellular sialic acid residues (16) , and as such, the viral HA is also thought to be a major contributor to the host range of the virus (34) . Previous work has shown that many of the triple-reassortant H3N2 viruses (including Sw/MN) contain 12 amino acid differences in their HA proteins that are unique to the swine viruses and that are not present in the most closely related human H3 virus HA proteins (including the Sw/ONT HA protein) (13, 40) . It is possible that these amino acid differences in the HA protein could account for at least part of the observed differences in infectivity and replication efficiency. In addition, the triple-reassortant H3N2 swine viruses contain gene segments of the classical swine influenza virus lineage (NP, M, and NS genes) and the avian influenza virus lineage (PA and PB2 polymerase genes), while they maintain the human influenza virus HA, NA, and PB1 genes (13, 40) , and the NP of influenza virus is considered to be a strong determinant of the influenza virus host range (27, 28, 31) . Therefore, it is also possible that this overall constellation of genes is important for efficient replication of these viruses in the porcine host. Studies being conducted in our laboratory with reverse genetically engineered viruses are addressing which gene segment or combination of gene segments is responsible for the differences in replication efficiencies between Sw/ONT and Sw/MN observed in this study.
